Pharma Data Breach Fiasco: Cencora’s $250B Security Slip-Up Exposes Millions
Big pharma’s data theft saga continues as Cencora’s February breach spills over, affecting health details from GlaxoSmithKline to Novartis. The $250-billion firm, formerly AmerisourceBergen, faces scrutiny as pharma giants report losses to California’s AG. How many individuals are impacted remains unclear.
Hot Take:
Who knew pharmaceutical data breaches could be the next big pill to swallow? Cencora’s breach has more side effects than a bad infomercial, and now the whole pharma industry is scrambling to find the right prescription for their data security woes!
Key Points:
- More than a dozen pharmaceutical suppliers reported data theft due to Cencora’s February breach.
- Notified individuals’ data includes names, addresses, birth dates, health diagnoses, and medication details.
- No current evidence suggests the stolen data has been used fraudulently.
- Cencora’s breach did not impact company operations materially, but future financial impacts are uncertain.
- California Attorney General was informed, but the total number of affected individuals remains unclear.
Already a member? Log in here